Samuel Stolpe, PharmD, MPH is the Head of Healthcare Quality Strategy at Johnson & Johnson. In this role, Sam leads a team responsible for the organization’s value-based payment strategy focused on trusted partnerships in achieving equitable care, health, and value, as well as improved care experiences for providers and patients.

A pharmacist and epidemiologist by training, Sam has spent his career at the nexus of healthcare quality improvement, business, public policy and research. Sam came to J&J in 2021 from the National Quality Forum (NQF) where he oversaw the work of the NQF Measure Applications Partnership—a series of committees that provided input to the Centers for Medicare & Medicaid Services for measures within federal quality and performance programs. Sam also led quality measure endorsement work for multiple NQF committees, NQF’s strategic initiatives related to measurement architecture, and NQF’s work on opioid measure frameworks.

Prior to NQF, Sam’s previous work has been focused on leveraging healthcare quality measures and emerging technologies to improve patient outcomes. Sam has previously served as Vice President, Private Sector at STCHealth and as Senior Director, Quality Strategies at the Pharmacy Quality Alliance. Sam was the inaugural fellow at the National Association of Chain Drug Stores where his work was focused on health outcomes research projects. Sam has also worked as a community pharmacist and holds an adjunct faculty position at Howard University.

Sam has a Master of Public Health degree from Harvard University and a Doctor of Pharmacy degree from Howard University.